Novartis A G shares owned by Simplex Trading
Quarter-by-quarter ownership of Novartis A G shares owned by Simplex Trading
from 13F filings
Historical chart of Simplex Trading investment in Novartis A G
Tip: Access up to 7 years of quarterly data
All positions including Novartis A G held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Novartis A G by Simplex Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $11M | 97k | 110.33 |
| 2024-06-30 | $13M | 129k | 102.97 |
| 2024-03-31 | $11M | 117k | 91.90 |
| 2023-12-31 | $3.7M | 132k | 28.02 |
| 2023-09-30 | $18M | 177k | 101.86 |
| 2023-06-30 | $36M | 355k | 100.91 |
| 2023-03-31 | $36M | 393k | 92.00 |
| 2022-12-31 | $54M | 593k | 90.72 |
| 2022-09-30 | $33M | 437k | 76.01 |
| 2022-06-30 | $17M | 198k | 84.53 |
| 2022-03-31 | $16M | 179k | 87.75 |
| 2021-12-31 | $7.1M | 78k | 91.65 |
| 2021-09-30 | $7.1M | 78k | 91.65 |
| 2021-06-30 | $7.1M | 78k | 91.24 |
| 2021-03-31 | $9.2k | 1.1k | 8.55 |
| 2020-12-31 | $14k | 1.4k | 9.44 |
| 2020-09-30 | $14k | 1.6k | 8.70 |
| 2020-06-30 | $14k | 1.6k | 8.73 |
| 2020-03-31 | $9.9k | 1.2k | 8.24 |
| 2019-12-31 | $5.4k | 567 | 9.47 |
| 2019-09-30 | $11k | 1.2k | 8.69 |
| 2019-06-30 | $8.8k | 965 | 9.13 |
| 2019-03-31 | $598 | 520 | 1.15 |
| 2018-12-31 | $2.2k | 255 | 8.58 |
| 2018-09-30 | $2.9k | 334 | 8.61 |
| 2018-06-30 | $4.7k | 624 | 7.55 |
| 2018-03-31 | $107k | 394 | 271.57 |
| 2017-12-31 | $88k | 391 | 225.06 |
| 2017-09-30 | $58k | 215 | 269.77 |
| 2017-06-30 | $134k | 316 | 424.05 |
| 2017-03-31 | $17k | 141 | 120.57 |
| 2016-12-31 | $36k | 293 | 122.87 |
| 2016-09-30 | $9.0k | 356 | 25.28 |
| 2016-06-30 | $56k | 259 | 216.22 |
| 2016-03-31 | $16k | 283 | 56.54 |
| 2015-12-31 | $14k | 190 | 73.68 |
| 2015-09-30 | $19k | 294 | 64.63 |
| 2015-06-30 | $9.0k | 94 | 95.74 |
| 2015-03-31 | $57k | 121 | 471.07 |
| 2014-12-31 | $23k | 107 | 214.95 |
Top funds holding Novartis A G
View all funds holding Novartis A G